TNSN08345A1 - Cancer treatments - Google Patents

Cancer treatments

Info

Publication number
TNSN08345A1
TNSN08345A1 TNP2008000345A TNSN08345A TNSN08345A1 TN SN08345 A1 TNSN08345 A1 TN SN08345A1 TN P2008000345 A TNP2008000345 A TN P2008000345A TN SN08345 A TNSN08345 A TN SN08345A TN SN08345 A1 TNSN08345 A1 TN SN08345A1
Authority
TN
Tunisia
Prior art keywords
cancer treatments
oxaliplatin
liposome
relates
encapsulated
Prior art date
Application number
TNP2008000345A
Inventor
Boulikas Parthenios
Original Assignee
Boulikas Parthenios
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boulikas Parthenios filed Critical Boulikas Parthenios
Publication of TNSN08345A1 publication Critical patent/TNSN08345A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The present invention relates to liposome comprising encapsulated oxaliplatin and methods for making encapsulated oxaliplatin. The invention also relates to liposomes comprising oxaliplatin and another anticancer drug. The liposome sof the invention are useful in cancer treatments.
TNP2008000345A 2006-03-03 2008-09-03 Cancer treatments TNSN08345A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GR20060100144A GR20060100144A (en) 2006-03-03 2006-03-03 Cancer treatment using oxaliplatin encapsulated into liposomes and co-encapsulation into the liposome particle of more than one pharmaceutical preparations, or genes
PCT/GR2007/000015 WO2007099377A2 (en) 2006-03-03 2007-03-05 Cancer treatments

Publications (1)

Publication Number Publication Date
TNSN08345A1 true TNSN08345A1 (en) 2009-12-29

Family

ID=38325437

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2008000345A TNSN08345A1 (en) 2006-03-03 2008-09-03 Cancer treatments

Country Status (17)

Country Link
US (1) US20090053302A1 (en)
EP (1) EP2001441A2 (en)
JP (1) JP2009528340A (en)
KR (1) KR20090023548A (en)
CN (1) CN101522172A (en)
AU (1) AU2007220263A1 (en)
BR (1) BRPI0707059A2 (en)
CA (1) CA2644566A1 (en)
EA (1) EA200801912A1 (en)
GR (1) GR20060100144A (en)
MA (1) MA30314B1 (en)
MX (1) MX2008011263A (en)
NO (1) NO20083927L (en)
RS (1) RS20080388A (en)
TN (1) TNSN08345A1 (en)
WO (1) WO2007099377A2 (en)
ZA (1) ZA200807934B (en)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9186322B2 (en) * 2002-08-02 2015-11-17 Insmed Incorporated Platinum aggregates and process for producing the same
US9107824B2 (en) 2005-11-08 2015-08-18 Insmed Incorporated Methods of treating cancer with high potency lipid-based platinum compound formulations administered intraperitoneally
KR20080094473A (en) * 2007-04-20 2008-10-23 한국화학연구원 Anionic lipid nanosphere and preparation method of the same
ES2465477T3 (en) * 2008-01-28 2014-06-05 Nanocarrier Co., Ltd. Pharmaceutical composition and combined drug
TWI468188B (en) * 2008-01-30 2015-01-11 Univ Tokushima Anti-cancer effect enhancers consisting of oxaliplatin liposomal preparations and anticancer agents comprising the formulation
WO2009111648A1 (en) * 2008-03-05 2009-09-11 Vicus Therapeutics, Llc Compositions and methods for mucositis and oncology therapies
EP2123258A1 (en) * 2008-05-23 2009-11-25 Liplasome Pharma A/S Liposomes for drug delivery
US20120135064A1 (en) * 2009-05-27 2012-05-31 Northeastern University Conjugated nanodelivery vehicles
WO2011034394A2 (en) * 2009-09-21 2011-03-24 주식회사 중외제약 Oxaliplatin nanoparticles and method for preparing same
JP5817053B2 (en) * 2010-04-02 2015-11-18 国立大学法人 千葉大学 Liposomes with tumor specificity
CN102133176B (en) * 2011-03-22 2012-09-05 济南宏瑞创博医药科技开发有限公司 Oxaliplatin micelle preparation, preparation method and application thereof
JP5378469B2 (en) 2011-08-11 2013-12-25 学校法人 日本歯科大学 Medicinal drugs
SG10201701063WA (en) 2012-08-10 2017-04-27 Taiho Pharmaceutical Co Ltd Stable oxaliplatin-encapsulating liposome aqueous dispersion and method for stabilizing same
MA37931A1 (en) * 2012-08-13 2016-07-29 Teni Boulikas Improved methods for treating cancer with reduced renal toxicity
EP2882419A4 (en) * 2012-08-13 2016-05-18 Regulon Inc Methods for treatment of cancer using lipoplatin
EP2892524B1 (en) 2012-09-04 2020-11-25 Eleison Pharmaceuticals, LLC Preventing pulmonary recurrence of cancer with lipid-complexed cisplatin
EA023757B1 (en) * 2012-12-24 2016-07-29 Общество С Ограниченной Ответственностью "Технология Лекарств" Method of producing oxaliplatin liposome form
CN105451720A (en) * 2013-03-13 2016-03-30 马林克罗特有限公司 Liposome oxaliplatin compositions for cancer therapy
DK2979700T3 (en) * 2013-03-27 2019-01-21 Taiho Pharmaceutical Co Ltd ANTITUMUM AGENT CONTAINING A LOW IRINOTECAN HYDROCHLORIDE HYDRATE
CN103622912B (en) * 2013-12-05 2016-02-24 常州金远药业制造有限公司 doxorubicin hydrochloride-docetaxel or paclitaxel liposome preparation and preparation method thereof
AU2016219004A1 (en) * 2015-02-13 2017-09-07 Op Nano Co., Ltd. Compositions and methods of tumor treatment utilizing nanoparticles
CN107530291A (en) 2015-03-03 2018-01-02 奎尔波特股份有限公司 Double heavy duty liposomal pharmaceutical preparations
CN107530283A (en) 2015-03-03 2018-01-02 奎尔波特股份有限公司 Combine liposomal pharmaceutical preparation
KR101687735B1 (en) * 2015-09-18 2016-12-19 서울대학교 산학협력단 Method for production of liposome powder with novel freeze drying supplement and novel solvent for phosphlipid
US20190307690A1 (en) * 2016-05-03 2019-10-10 The American University In Cairo Liposomal Delivery Systems for Oxaliplatin and in Dual Drug Delivery in Combination with Chemo-sensitizing and Chemo-therapeutic agents
US10940112B2 (en) 2016-05-04 2021-03-09 L.E.A.F. Holdings Group Llc Targeted liposomal gemcitabine compositions and methods thereof
CN106074379B (en) * 2016-07-11 2019-01-25 中国科学院上海药物研究所 Pegylation oxaliplatin prodrug and its preparation method and application
CN112656764B (en) * 2020-12-28 2022-09-02 吉林大学 Paclitaxel platinum co-loading targeting long-circulating liposome and application thereof
CN114814023B (en) * 2022-04-24 2024-07-30 江苏省中医院 Application of lipid molecules as predictive markers of gastric cancer chemotherapeutic drug resistance

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6060080A (en) * 1990-07-16 2000-05-09 Daiichi Pharmaceutical Co., Ltd. Liposomal products
CA2046997C (en) * 1990-07-16 2000-12-12 Hiroshi Kikuchi Liposomal products
US6511676B1 (en) * 1999-11-05 2003-01-28 Teni Boulikas Therapy for human cancers using cisplatin and other drugs or genes encapsulated into liposomes
WO2001093836A2 (en) * 2000-06-09 2001-12-13 Teni Boulikas Encapsulation of polynucleotides and drugs into targeted liposomes
CA2383259A1 (en) * 2002-04-23 2003-10-23 Celator Technologies Inc. Synergistic compositions
JP3415131B1 (en) * 2002-06-03 2003-06-09 メビオファーム株式会社 Liposome preparation
US20040022842A1 (en) * 2002-06-03 2004-02-05 Mebiopharm Co., Ltd. Liposome preparations containing oxaliplatin
BRPI0313191A2 (en) * 2002-08-02 2016-11-08 Transave Inc composition and process for producing a platinum aggregate and pharmaceutical formulation
CA2524478A1 (en) * 2003-05-02 2004-11-18 Aronex Pharmaceuticals, Inc. Lipid platinum complexes and methods of use thereof
WO2005000266A2 (en) * 2003-05-22 2005-01-06 Neopharm, Inc. Liposomal formulations comprising a combination of two or more active agents

Also Published As

Publication number Publication date
EA200801912A1 (en) 2009-02-27
NO20083927L (en) 2008-09-15
AU2007220263A1 (en) 2007-09-07
GR20060100144A (en) 2007-10-17
KR20090023548A (en) 2009-03-05
WO2007099377A2 (en) 2007-09-07
CN101522172A (en) 2009-09-02
CA2644566A1 (en) 2007-09-07
MA30314B1 (en) 2009-04-01
MX2008011263A (en) 2008-12-12
JP2009528340A (en) 2009-08-06
EP2001441A2 (en) 2008-12-17
RS20080388A (en) 2009-07-15
ZA200807934B (en) 2009-11-25
WO2007099377A3 (en) 2008-04-17
US20090053302A1 (en) 2009-02-26
BRPI0707059A2 (en) 2011-04-19

Similar Documents

Publication Publication Date Title
TNSN08345A1 (en) Cancer treatments
MX2007010996A (en) Novel liposome compositions.
MY146112A (en) Long-term feed - cancer patient
HK1146469A1 (en) Agent for enhancing anti-tumor effect comprising oxaliplatin liposome preparation, and anti-tumor agent comprising the liposome preparation
IN2015DN00255A (en)
WO2008137867A3 (en) Compositions comprising mir34 therapeutic agents for treating cancer
WO2008015383A8 (en) Bmp-9 and bmp-10 and their use in breast and prostate cancer therapies
MY171994A (en) Use of sigma ligands in bone cancer pain
MX2014000199A (en) Combination therapy.
TN2011000292A1 (en) Amino pyrazole compound
WO2009129387A3 (en) Cationic lipids and uses thereof
WO2009140675A3 (en) Combination therapy with pm00104 and another antitumor agent
WO2008030818A3 (en) Novel liposome compositions
WO2007105015A3 (en) DERIVATIVES OF 18ß-GLYCYRRHETINIC ACID
WO2010121164A3 (en) 1,4-benzodiazepinone compounds and their use in treating cancer
WO2009095261A3 (en) Vaccine compositions
WO2008063808A3 (en) Encapsulated peptide amphiphile nanostructures
HK1100484A1 (en) Application of n-butylidenephthalide in preparing cancer treatment medication
WO2008060945A3 (en) Diagnosis and treatment of breast cancer
WO2012154942A3 (en) Ceramide anionic liposome compositions
SI2147122T1 (en) Enzymatic anticancer therapy
EP1789064A4 (en) Improved anticancer treatment
EP1635764A4 (en) Conjugate for the specific targeting of anticancer agents to cancer cells and production thereof
CA139930S (en) Chocolate confectionery
MXPA05008902A (en) Menthol solutions of drugs.